Death Rates in Melanoma Fell Markedly Following the Proliferation of New Types of Therapies
Patients are now able to get immunotherapies and targeted therapies at their local clinics, rather than having to travel to academic medical centers.
Skin Cancer
SKIN CANCER ADVISOR
FEATURED CONTENT
-
-
Tumors With High Levels of Microsatellite Instability Responded Well to Treatment With PD-1 Inhibitors
New research has linked microsatellite instability and the number of insertion/deletion mutations present in a tumor to clinical response to checkpoint inhibition. -
Personalized Cancer Vaccine NEO-PV-01 Shows Promise in Early Trials in Advanced Melanoma
Early results from a small clinical trial of a new personalized cancer vaccine called NEO-PV-01 in advanced melanoma appear promising — and no significant toxicity issues have yet been revealed. -
In-House or Centralized Testing? Debating Whether Genomic Sequencing Is Best Conducted at Home
Genomic analysis of tumors and tests measuring certain biomarkers can be done in-house or sent out. What are the costs and benefits of each approach? -
A Novel Method for Biomarker Discovery in Clinical Trials
A new study reveals a unique method of biomarker discovery that has the potential to be used to identify responder subpopulations in clinical trials.
VIDEO SERIES
Recent Advances in Melanoma Therapy
Targeted Treatments and Immunotherapies for Melanoma
Tailoring Treatments in Melanoma
Drug Resistance in Melanoma
Affordability of Melanoma Care
Melanoma: Treatment-induced Toxicity
Immunotherapy: A Decade of Improvements in Melanoma
Should Patients With Melanoma Receive Targeted Therapy or Immunotherapy First?
Melanoma: Checkpoints in the Pipeline
Targeting Therapy for Melanoma Subtypes
Melanoma: Targetable Genes in the Pipeline
Clinical Trials in Melanoma
SKIN CANCER NEWS
Determining Risk Factors for Recurrence of Primary Localized Cutaneous Melanoma
Time Between Initial Surgery and First Distant Recurrence Not Predictive of Response to Systemic Therapy in Metastatic Melanoma
Calculated Tumor Area Has Prognostic Value for Melanoma
Machine Versus Physician: Assigning Diagnoses to Pigmented Skin Lesions
Carbamazepine and Lamotrigine Associated With Increased Risk for SCC
Want to read more?
Please login or register first to view this content.
Next post in Skin Cancer
